Hyperuricemia and gout reduction by SGLT2 inhibitors in diabetes and heart failure
Zepbound and Wegovy are FDA-approved for weight loss
The research tells a more complicated story
Education topics may include adherence to medications, dietary potassium intake, and scheduled blood tests (for potassium monitoring) and discussions on: Sick-day management advice Importance of informing health-care team about any changes in medical conditions and medications Avoidance of excessive fist clenching during blood collection and doing blood tests immediately after potassium ingestion, if possible Conclusion Hyperkalemia is common in individuals with CKD and diabetes, and is associated with increased risk for mortality, cardiovascular events, hospitalizations, and intensive care unit admissions
Scientific interest in the compound reflects its value as a laboratory tool only and does not constitute a claim of therapeutic, cosmetic, or clinical benefit
Serious but less common risks include pancreatitis, gallbladder problems, kidney issues, and worsening of diabetic retinopathy in people with a history of retinopathy
